藥物成份

共有 20838 個藥物成份

The kit contains one each lyophilized vials of isoniazid and rifampin and four vials of SIRE Supplement. \nApproximate Formula Per Vial Lyophilized drug: Isoniazid.....33.2 μg、\nApproximate Formula Per Vial Lyophilized drug: Rifampin.....332 μg

• 關聯藥證數量: 1

The kit contains one each lyophilized vials of streptomycin, isoniazid, rifampin and ethambutol and eight vials of SIRE Supplement.Approximate Formula Per Vial Lyophilized drug: Streptomycin……..332μgApproximate Formula Per Vial Lyophilized drug: Isoniazid………….33.2μgApproximate Formula Per Vial Lyophilized drug: Rifampin………….332μgApproximate Formula Per Vial Lyophilized drug: Ethanbutol……….1660μg

• 關聯藥證數量: 1

The kit contains one vial Lyophilized streptomycin and two vials of SIRE Surpplement.\nApproximate Formula* Per Vial Lyophilized drug: Streptomycin.................664 μg

• 關聯藥證數量: 1

The kit contains one vial lyophilized isoniazid and two\nvials of SIRE Supplement.\nApproximate Formula Per Vial Lyophilized drug：Isoniazid.........66.4ug

• 關聯藥證數量: 1

The lyophilized HDL Calibrator is prepared from human serum.

• 關聯藥證數量: 1

The matrix for the UTAK Bi-Level AED II Control is prepared from normal human serum. The analytes are adjusted to the desired concentration range for each lot prepared. Quality control bofore, during, and after the preparation of the control material ensure that each lot is of the same quality.

• 關聯藥證數量: 1

The matrix for the UTAK Bi-Level Trace Elements Control is prepare from normal human whole blood. The metal concentrations are adjusted to the desired concentration range for each lot prepared. Quality control before, during, and after the preparation of the control material ensure that each lot is of the same quality.

• 關聯藥證數量: 1

The matrix for the UTAK Four-Level Lead Control is prepared from normal human whole blood. The metal concentrations are adjusted to the desired concentration range for each lot prepared. Quality control before, during, and after the preparation of the control material ensure that each lot is of the same quality.

• 關聯藥證數量: 1

The matrix for the UTAK Homocysteine Control is prepare from normal human whole blood.

• 關聯藥證數量: 1

The matrix for the UTAK Metals is prepared from normal human whole blood. The metal concentrations are adjusted to the desired concentration range for each lot prepared. Quality control before, during, and after the preparation of the control material ensure that each lot is of the same quality.

• 關聯藥證數量: 1

The matrix for the UTAK Tri-Level Immunosuppressants Control is prepared from normal human whole blood. The analytes are added and adjusted to the desired concentration range for each lot prepared.

• 關聯藥證數量: 1

The matrix is prepared from normal human whole blood. The analytes are added and adjusted to the desired concentration range for each lot prepared. Quality control before, during, and after the preparation of the control material ensures that each lot is of the same quality.

• 關聯藥證數量: 1

The medium tube contains 110 μL of fluorescent indicator and 7 mL of PZA broth. The pH is adjusted to 5.9. \nApproximate Formula Per L of Purified Water:\nModified Middlebrook 7H9 broth 5.9g\nCasein peptone 1.25g\nKit contains two lyophilized vials of pyrazinamide and six vials of PZA Supplement.\nApproximate Formula Per Vial Lyophilized drug: Pyrazinamide 20000 μg\nSupplement contains 15 mL of enrichment\nApproximate Formula Per L Purified Water: \nBovine albumin 50.0g\nDextrose 20.0g\nPolyoxyethylene stearate (POES) 1.1g \nCatalase 0.03g\nOleic Acid 0.1g\n

• 關聯藥證數量: 1

The monoclonal antibody is supplied as 50 ug purified immunoglobulin in 2.0 mL (25 ug/mL) ofphosphate-buffered saline (PBS). The FITC conjugate is supplied as 100 ug in 2.0 mL (50 ug/mL)of PBS. The PerCP conjugate is supplied as 50 ug in 2.0 mL (25 ug/mL) of PBS. The PerCP-Cy5.5 conjugate is supplied as 6 ug in 1.0 mL (6 ug/mL) of PBS. The APC conjugate is supplied as 12.5ug in 0.5 mL (25 ug/mL) of PBS. The APC-Cy7 conjugate is supplied as 50 ug in 0.5 mL (100 ug/mL) of PBS. PBS contains gelatin and 0.1% sodium azide. Twenty microliters (20 uL) of the monoclonal antibody or the FITC-, PerCP-, or PerCP-Cy5.5–conjugated antibody stains 106 PBMCs. Five microliters (5 uL) of the APC- or APC-Cy7–conjugated antibody stains 106 PBMCs.

• 關聯藥證數量: 1

The nominal content of Silymarin is within the range 30% m/m to 65% m/m as silybin ( dry extract C25H22O10 ).

• 關聯藥證數量: 1

The nominal content of silymarin is within the range 30% m/m to 65% m/m as silybin (dried extract).

• 關聯藥證數量: 1

The origin of the biological additives is as follows:

• 關聯藥證數量: 1

The polyclonal rabbit antisera are produced by immunization with well defined reference strains. They have been rendered specific by absorption of antibodies against other E. coli antigens.

• 關聯藥證數量: 1

The product are sterile plastic syringes which contain calcium- balanced Heparin.

• 關聯藥證數量: 1

The product composed of stabilized human red cell suspended in a buffer fluid and preservatives.

• 關聯藥證數量: 1

The product is a buffered bicarbonate solution in equilibrium with predetermined levels oxygen, carbon dioxide and nitrogen.\nThe mean values and the range of the analytes are specific for each lot of the product.

• 關聯藥證數量: 1

The product is a human base control with addedconstituents of animal origin, chemicals and preservatives. The mean values and the range of the analytes are specific for each lot of the product.

• 關聯藥證數量: 1

The product is a suspension of human blood and simulated platelets stabilized in a buffered medium.\nThis product is a stabilized liquid product manufactured under rigid quality control standards.

• 關聯藥證數量: 1

The product is prepared form human serum added constituents of human and animal origins,therapeutic drugs,stabilizers and preservatives.The control is provided in lyophilized form for increased stability.

• 關聯藥證數量: 1

The product is prepared form human serum with added consitituents of human and animal origins, chemicals and stabilizers. The control is provided in lyophilized form for increased stability.

• 關聯藥證數量: 1

The product is prepared form human serum with added consitituents of human and animal origins, pure chemicals and stabilizers. The control is provided in lyophilized form for increased stability.

• 關聯藥證數量: 1

The product is prepared form human serum with added constituents of human and animal origins.

• 關聯藥證數量: 1

The product is prepared form human serum with added constituents of purified biochemicals tissue extracts of human and animal origin), chemicals, therapeutic drugs, preservative and stabilizers. The control is provided in lyophilized form for increased stability.

• 關聯藥證數量: 1

The product is prepared form human serum with added drugs, constituents of human and animal origin, stabilizers and preservatives. The mean values were derived from replicate analyses and are specific for each lot of product.

• 關聯藥證數量: 1

The product is prepared form human serum with added serum protein, constituents of animal origins, preservatives and stabilizers. The control is provided in liquid form for convenience.

• 關聯藥證數量: 1

The product is prepared from bovine serum albumin with chemicals, stabilizers and preservatives added. The control is provided in liquid form for convenience.

• 關聯藥證數量: 1

The product is prepared from human plasma, human serum and human proteins. Preservatives and stabilizers have been added to maintain product integrity.

• 關聯藥證數量: 1

The product is prepared from human serum iwth added constituents of human and animal origins, preservatives and stabilizers.

• 關聯藥證數量: 1

The product is prepared from human serum to which purified biochemicals (tissue extract of human and animal origin), chemicals, therapeutic drugs, preservatives and stabilizers have been added. The mean values and the range of the analytes are specific for each lot of the product.

• 關聯藥證數量: 1

The product is prepared from human serum with added chemicals and constituents of human and animal origin. The control is provided in lyophilized form for increased stability.

• 關聯藥證數量: 1

The product is prepared from human serum with added consitituents of human and animal origins, pure chemicals and stabilizers. The control is provided in lyophilized form for increased stability.

• 關聯藥證數量: 1

The product is prepared from human serum with added constituents of human and animal origin, chemicals; therapeutic drugs, stabilizers and preservatives.The control is provided in liquid form.\nThe mean values and the range of the analytes are specific for each lot of the product.

• 關聯藥證數量: 1

The product is prepared from human serum with added constituents of human and animal origins, chemicals and therapeutic drugs. Level 1 also contains stabilizers. The control is provided in lyophilized form.The mean values and the range of the analytes are specific for each lot of the product.

• 關聯藥證數量: 1

The product is prepared from human serum with added constituents of human and animal origins, pure chemicals and stabilizers. The control is provided in lyophilized form for increased stability.

• 關聯藥證數量: 1

The product is prepared from human serum with added constituents of purified biochemicals(tissue extract form human and animal origins), chemicals, therapeutic drugs, preservatives and stabilizers.

• 關聯藥證數量: 1

The product is prepared from human urine with added constituents of human and animal origins, chemicals, preservatives and stabilizers. The mean values and the ranges of the analytes are specific for each lot of the product.

• 關聯藥證數量: 1

The product is prepared from human whole blood and contains preservatives and stabilizers. The control is provided in lyophilized form for increased stability.

• 關聯藥證數量: 1

The product is prepared from human whole blood with added chemicals, and stabilizers. The control is provided in lyophilized from for increased stability.

• 關聯藥證數量: 1

The product is prepared from human whole blood with pure chemicals, stabilizers added.

• 關聯藥證數量: 1

The product is prepared from human whole blood, with added chemicals, and stabilizers. The control is provided in lyophilized form for increased stability.

• 關聯藥證數量: 1

The products are micro blood collection tubes without anticoagulant, the gel of SST are easy to separate.

• 關聯藥證數量: 1

The products are prepared in a buffered sodium chloride diluent containing bovine albumin, glycine, and a surfactant to prevent adherence of the cell button to the test tube.

• 關聯藥證數量: 1

The quality control material is prepared from human serum with nonserum constituents added. No preservatives or stabilizers were added. The constituents were adjusted to the levels listed in Expected Values.

• 關聯藥證數量: 1

The quality control material is prepared from human serum with recombinant human CK-MB, human proteins, and stabilizing/bacteriostatic agents added.

• 關聯藥證數量: 1

The reaction device contains a drug-protein conjugate coated membrane and a pad containing the antibody-dye conjugate in a protein matrix containing a 0.1% sodium azide.

• 關聯藥證數量: 1

The reaction strip contains dye-conjugated and immobilized antibodies in a protein matrix.

• 關聯藥證數量: 1

The reagent contains a near-colloidal particle activator and a chloroform extract of rabbit brain with buffer and stabilizers. Calcium Cloride:0.025 M.

• 關聯藥證數量: 1

The reagent is provided in 1ml of buffered saline with 0.1% sodium azide. It contains FITC-labeled CD3, clone SK7、\nPE-labeled CD16, clone B73.1、\nCD56, clone NCAM 16.2、\nPerCP-Cy5.5-labeled CD45, clone 2D1 (HLe-1)、\nPE-Cy7-labeled CD4, clone SK3、\nAPC-labeled CD19, clone SJ25C1、\nAPC-Cy7-labeled CD8, clonenSK1.

• 關聯藥證數量: 1

The reagent red cells are suspended in a preservation medium.

• 關聯藥證數量: 1

The reagent red cells are suspended in a special preservation medium.\nCoombs Control Cell (Strong) are IgG sensitised Group 0 Rhesus D-positive human red cells that have been sensitised in vitro with different amounts of anti-D (IgG) antibodies.

• 關聯藥證數量: 1

The reagent set is sufficient for 100 tests and consists of the following reagents :1.<5% Quinidine ANTISERUM (Mouse)in buffer containing protein as stabilizer and <0.1% sodium azide as preservative (3mL). Cap label “A”2.<0.1% Quinidine -fluorescein TRACER in buffer containing protein as stabilizer and <0.1% sodium azide as preservative (3mL). Cap label “T”3.PRE-TREATMENT BUFFER containing a surfactant and <0.1% sodium azide as preservative (3mL). Cap label “B”

• 關聯藥證數量: 1

The reagent set is sufficient for 100 tests and consists of the following reagents:\n1. < 5% Digitoxin ANTISERUM (Rabbit) in buffer containing protein as stabilizer and < 0.1% sodium azide as preservative (3 mL). Cap label A\n2. < 0.1% Digitoxin-fluorescein TRACER in buffer containing protein as stabilizer, a surfactant and < 0.1% sodium azide as preservative (3 mL). Cap label T\n3. PRE-TREATMENT BUFFER containing surfactant (3 mL). Cap label B\nThe INNOFLUOR DIGITOXIN Calibrator Set consists of human serum and <0.1% sodium azide as preservative with 0, 5.0, 10.0, 20.0, 40.0, 80.0 ng/ml digitoxin:\nEach calibrator vial contains 2.5 mL, sufficient for ten dupli-cate calibration curves.

• 關聯藥證數量: 1

The reagent set is sufficient for 150 tests and consists of the following reragents:\n1. CerticanR Antibody Reagent (5 mL); <5% rabbit antisera in buffer containing protein as stabilizer and <0.1% sodium azide as preservative. Vial cap label “A”.\n2. CerticanR Tracer Reagent (5 mL); <1% fluorescein tracer in buffer containing protein as stabilizer, a surfactant, and <0.1% sodium azide as preservative. Vial cap labeled “T”.\n3. CerticanR Pretreatment Buffer (5 mL); tris buffer, detergent, and <0.1% sodium azide as preservative. Vial cap labeled “B”.\n4. Precipitation Reagent (7.5 mL); containing precipitating reagent, and <0.1% sodium azide.

• 關聯藥證數量: 1

The reagents include special substance of CD 13 are intended for use in a diagnostic application for identification and quantification of an individual chemical substance.

• 關聯藥證數量: 1

The reagents include special substance of CD 14 are intended for use in a diagnostic application for identification and quantification of an individual chemical substance.

• 關聯藥證數量: 1

The reagents include special substance of CD 15 are intended for use in a diagnostic application for identification and quantification of an individual chemical substance.

• 關聯藥證數量: 1

The reagents include special substance of CD 38 are intended for use in a diagnostic application for identification and quantification of an individual chemical substance.

• 關聯藥證數量: 1

The reagents include special substance of CD 41a are intended for use in a diagnostic application for identification and quantification of an individual chemical substance.

• 關聯藥證數量: 1

The reagents include special substance of CD 57 are intended for use in a diagnostic application for identification and quantification of an individual chemical substance.

• 關聯藥證數量: 1

The reagents include special substance of CD 71 are intended for use in a diagnostic application for identification and quantification of an individual chemical substance.

• 關聯藥證數量: 1

The reagents include special substance of CD10 are intended for use in a diagnostic application for identification and quantification of an individual chemical substance.

• 關聯藥證數量: 1

The reagents include special substance of CD117 are intended for use in a diagnostic application for identification and quantification of an individual chemical substance.

• 關聯藥證數量: 1

The reagents include special substance of CD11b are intended for use in a diagnostic application for identification and quantification of an individual chemical substance.

• 關聯藥證數量: 1

The reagents include special substance of CD16 are intended for use in a diagnostic application for identification and quantification of an individual chemical substance.

• 關聯藥證數量: 1

The reagents include special substance of CD2 are intended for use in a diagnostic application for identification and quantification of an individual chemical substance.

• 關聯藥證數量: 1

The reagents include special substance of CD20 are intended for use in a diagnostic application for identification and quantification of an individual chemical substance.

• 關聯藥證數量: 1

The reagents include special substance of CD22 are intended for use in a diagnostic application for identification and quantification of an individual chemical substance.

• 關聯藥證數量: 1

The reagents include special substance of CD23 are intended for use in a diagnostic application for identification and quantification of an individual chemical substance.

• 關聯藥證數量: 1

The reagents include special substance of CD25 are intended for use in a diagnostic application for identification and quantification of an individual chemical substance.

• 關聯藥證數量: 1

The reagents include special substance of CD33 are intended for use in a diagnostic application for identification and quantification of an individual chemical substance.

• 關聯藥證數量: 1

The reagents include special substance of CD5 are intended for use in a diagnostic application for identification and quantification of an individual chemical substance.

• 關聯藥證數量: 1

The reagents include special substance of CD56(NCAM16.2) are intended for use in a diagnostic application for identification and quantification of an individual chemical substance.

• 關聯藥證數量: 1

The reagents include special substance of CD61 are intended for use in a diagnostic application for identification and quantification of an individual chemical substance.

• 關聯藥證數量: 1

The reagents include special substance of CD7(M-T701) are intended for use in a diagnostic application for identification and quantification of an individual chemical substance.

• 關聯藥證數量: 1

The sample consist of human blood and biologically simulated platelets stabilised in a buffered medium.

• 關聯藥證數量: 1

The solution contains Thiazole orange in phosphate-buffered saline with 0.1% sodium azide.

• 關聯藥證數量: 1

The sum of content of erythromycin A,erythromycin B, and erythromycin C is not less than 93.0% and not more than 100.5%, calculated with reference to the anhydrous substance.

• 關聯藥證數量: 1

The test contains anit-LH particles and anti-LH antibody coated on the membrane.

• 關聯藥證數量: 1

The test contains anti-hemoglobin antibody particles and anti-hemoglobin antibody coated on the membrance.

• 關聯藥證數量: 1

The test contains anti-hemoglobin antibody particles and anti-hemoglobin antibody coated on the membrane.

• 關聯藥證數量: 1

The test device contains H.pylori antigen coated particles and anti-human IgG coated on the membrane.

• 關聯藥證數量: 1

The test device contains anti-cTnI antibody coated particles and capture reagent coated on the membrane.

• 關聯藥證數量: 1

The test device contains anti-hCG and anti-hCG coated on the membrane.

• 關聯藥證數量: 1

The test device contains anti-hCG particles coated on the membrane.

• 關聯藥證數量: 1

The test devices contains anit-hCG particles coated on the membrane.

• 關聯藥證數量: 1

The test devices contains mouse monoclonal anti-Methamphetamine antibody-coupled particles and Methamphetamine-protein conjugate. A goat antibody is employed in the control line system.

• 關聯藥證數量: 1

The test sera are absorbed sera from immunized rabbits. The test reagents consist of a mixture of absorbed sera from immunized rabbits and monoclonal anitbodies. The Enteroclons contain only monoclonal antibodies.

• 關聯藥證數量: 1

The test strip contains Syphilis antigen coated particles and Syphilis antigen coated on the membrane.

• 關聯藥證數量: 1

The test strip contains anti-hCG antibody coated on the membrane.

• 關聯藥證數量: 1

The test strip contains reagent (human recombinant thromboplastin 15 U), as well as stabilizers, preservatives and additives.

• 關聯藥證數量: 1

The test strip contains：Glucose Oxidase (Aspergillus niger)≧0.08IU; Ferricyanide 48 μg. The vial (desiccant sleeve) contains approximately 65% molecular sieve.

• 關聯藥證數量: 1

The test tubes contain a lyophilized preparation of USP characterized heparin with added activator, stabilizers and buffers.

• 關聯藥證數量: 1

The testsera are absorbed sera from immuized rabbits. The test reagents consist of a mixture of absorbed sera from immunized rabbits and monoclonal antibodies. The Enteroclons contain only monoclinal antibodies.

• 關聯藥證數量: 1

The tubes are glass or plastic Vacutainer blood collection tubes contain anticoagulant Heparin.

• 關聯藥證數量: 1

The tubes are glass or plastic evacuated tubes with different amount of vacuum. (The tubes are with no anticoagulant)

• 關聯藥證數量: 1